Clinical and Laboratory Features of Pediatric Patients with COVID-19: Systematic Review and Meta-analysis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Although the identification of clinical and laboratory features in pediatric COVID-19 patients is essential in establishing an appropriate treatment plan, a systematic review and meta-analysis on the topic has yet to be reported. Methods: We searched MEDLINE, Embase, and Web of Science to access clinical and laboratory characteristics as well as clinical outcomes of children with COVID-19 infection. A meta-analysis using random-effect model was performed to estimate pooled prevalence and 95% confidence intervals. Results: Among the 532 studies initially collected, 12 articles were finally included in the meta-analysis. Among the investigated 320 pediatric patients with COVID-19, fever (48.2%) and cough (39.3%) were the most common symptoms. Almost one third of patients (30.4%) were asymptomatic. In laboratory findings, only 11.4% of pediatric patients experienced lymphocytopenia. Increased inflammatory markers including c-reactive protein (18.6%) and procalcitonin (32.4%) were observed. Only a few patients needed mechanical ventilation and intensive care support, and only one death was reported. Conclusion: Pediatric patients with COVID-19 infection exhibited milder symptoms and more favorable outcomes compared to adults. However, considering the high rate of asymptomatic pediatric patients, close monitoring is required to prevent community infection in asymptomatic conditions and hidden disease progression.
Abstract
Background: Although the identification of clinical and laboratory features in pediatric COVID-19 patients is essential in establishing an appropriate treatment plan, a systematic review and meta-analysis on the topic has yet to be reported. Methods: We searched MEDLINE, Embase, and Web of Science to access clinical and laboratory characteristics as well as clinical outcomes of children with COVID-19 infection. A meta-analysis using random-effect model was performed to estimate pooled prevalence and 95% confidence intervals. Results: Among the 532 studies initially collected, 12 articles were finally included in the meta-analysis. Among the investigated 320 pediatric patients with COVID-19, fever (48.2%) and cough (39.3%) were the most common symptoms. Almost one third of patients (30.4%) were asymptomatic. In laboratory findings, only 11.4% of pediatric patients experienced lymphocytopenia. Increased inflammatory markers including c-reactive protein (18.6%) and procalcitonin (32.4%) were observed. Only a few patients needed mechanical ventilation and intensive care support, and only one death was reported. Conclusion: Pediatric patients with COVID-19 infection exhibited milder symptoms and more favorable outcomes compared to adults. However, considering the high rate of asymptomatic pediatric patients, close monitoring is required to prevent community infection in asymptomatic conditions and hidden disease progression.
참고문헌 (34)
- Kelvin AA, "COVID-19 in children : the link in the transmission chain", Lancet Infect Dis, 20(6), pp.633~634 (2020)
- "Weekly operational update on COVID-19-7 December 2020"[URL]
- Lu X, "SARS-CoV-2 Infection in Children", N Engl J Med, 382(17), pp.1663~1665 (2020)
- Tregoning JS, "Respiratory viral infections in infants:causes, clinical symptoms, virology, and immunology", Clin Microbiol Rev, 23(1), pp.74~98 (2010)
- Campbell H, "Child pneumonia at a time of epidemiological transition", Lancet Glob Health, 3(2), pp.e65~e66 (2015)
- The World Health Oraganization, "Clinical management of severe acute respiratory infection(SARI)when COVID-19 disease is suspected", Interim guidance, 21(1), pp.734~ (2020)
- Tsang KW, "A cluster of cases of severe acute respiratory syndrome in Hong Kong", N Engl J Med, 348(20), pp.1977~1985 (2003)
- Assiri A, "Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study", Lancet Infect Dis, 13(9), pp.752~761 (2013)
- "JBI manual for evidence synthesis"[URL]
- Wan X, "Estimating the sample mean and standard deviation from the sample size, median, range and", or interquartile range, 2014, pp.14, 135~
- Su L, "The different clinical characteristics of corona virus disease cases between children and their families in China-the character of children with COVID-19", Emerg Microbes Infect, 9(1), pp.707~713 (2020)
- Zhou Y, "Clinical features and chest CT findings of coronavirus disease 2019 in infants and young children", Zhongguo dang dai er ke za zhi, 22(3), pp.215~220 (2020)
- Wei M, "Novel coronavirus infection in hospitalized infants under 1 year of age in China", JAMA, 323(13), pp.1313~1314 (2020)
- Li W, "Chest computed tomography in children with COVID-19 respiratory infection", Pediatr Radiol, 50(6), pp.796~799 (2020)
- Zheng F, "Clinical characteristics of children with coronavirus disease 2019 in Hubei, China", Curr Med Sci, 40(2), pp.275~280 (2020)
- Jiehao C, "A Case Series of children with 2019 novel coronavirus infection : clinical and epidemiological features", Clin Infect Dis, 71(6), pp.1547~1551 (2020)
- Liu H, "Clinical and CT imaging features of the COVID-19 pneumonia : Focus on pregnant women and children", J Infect, 80(5), pp.e7~e13 (2020)
- Liu W, "Detection of Covid-19 in children in early January 2020 in Wuhan, China", N Engl J Med, 382(14), pp.1370~1371 (2020)
- Qiu H, "Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study", Lancet Infect Dis, 20(6), pp.689~696 (2020)
- Wang D, "Clinical analysis of 31 cases of 2019novel coronavirus infection in children from six provinces (autonomous region) of northern China", Zhonghua er ke za zhi, 58(4), pp.269~274 (2020)
- Liu M, "High-resolution computed tomography manifestations of 5 pediatric patients With 2019 novel Coronavirus", J Comput Assist Tomogr, 44(3), pp.311~313 (2020)
- "Global surveillance for human infection with novel coronavirus (2019-ncov): interim guidance"[URL]
- "Protocol on prevention and control of COVID-19 (Edition 6)"[URL]
- Chen N, "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study", Lancet, 395(10223), pp.507~513 (2020)
- Rodriguez-Morales AJ, "Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis", Travel Med Infect Dis, 34, pp.101623~ (2020)
- Sun P, "Clinical characteristics of hospitalized patients with SARS-CoV-2 infection : A single arm meta-analysis", J Med Virol, 92(6), pp.612~617 (2020)
- Zhou F, "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study", Lancet, 395(10229), pp.1054~1062 (2020)
- Dong Y, "Epidemiological characteristics of 2143pediatric patients with 2019 Coronavirus disease in China", Pediatrics, 58(4), pp.712~713 (2020)
- Safadi M, "The challenging and unpredictable spectrum of COVID-19 in children and adolescents", Rev Paul Pediatr, 39, pp.e2020192~ (2020)
- Du W, "Clinical characteristics of COVID-19 in children compared with adults in Shandong Province, China", Infection, 48(3), pp.445~452 (2020)
- Mizumoto K, "Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19)cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020", Euro Surveill, 25(10), pp.2000180~ (2020)
- Al-Tawfiq JA, "Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19)", Travel Med Infect Dis, 35, pp.101608~ (2020)
- Rothe C, "Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany", N Engl J Med, 382(10), pp.970~971 (2020)
- Chan JF, "A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-toperson transmission : a study of a family cluster", Lancet, 395(10223), pp.514~523 (2020)